Tetramodal bladder preservation
Showing 1 - 25 of 4,273
Protocol for Muscle Invasive Urothelial Carcinoma of Urinary
Recruiting
- Bladder Cancer
- terta modal bladder preservation
-
Assiut, Assuit, EgyptAssuit university
Aug 13, 2022
Urothelial Carcinoma Trial (Disitamab Vedotin, radiotherapy)
Not yet recruiting
- Urothelial Carcinoma
- Disitamab Vedotin
- radiotherapy
- (no location specified)
Jun 20, 2023
Urinary Bladder Tumors Trial in Xi'an (drug, procedure, radiation)
Not yet recruiting
- Urinary Bladder Neoplasms
- Tislelizumab Injection
- +2 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Dec 26, 2022
Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab
Not yet recruiting
- Localized Muscle Invasive Bladder Urothelial Carcinoma
- Muscle-Invasive Bladder Carcinoma
- Sacituzumab govitecan
- Adaptive Radiotherapy
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 18, 2023
Invasive Bladder Cancer Trial in Spain (Durvalumab, Tremelimumab, Radiotherapy)
Active, not recruiting
- Invasive Bladder Cancer
- Durvalumab
- +2 more
-
Badalona, Barcelona, Spain
- +6 more
Mar 9, 2022
Urothelial Carcinoma Trial in France (optimal TURB)
Terminated
- Urothelial Carcinoma
- optimal TURB
-
Aix-en-Provence, France
- +30 more
Dec 10, 2021
Bladder Cancer Trial in Beijing (Intensity modulated radiation therapy, Radical cystectomy)
Completed
- Bladder Cancer
- Intensity modulated radiation therapy, Radical cystectomy
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Dec 15, 2020
Muscle-Invasive Bladder Carcinoma Trial in Seoul
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Dec 24, 2020
Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)
Completed
- Bladder Cancer
- induction cisplatin
- +13 more
-
Atlanta, Georgia
- +10 more
May 23, 2022
Infiltrating Bladder Urothelial Carcinoma Trial in Los Angeles (Quality-of-Life Assessment, Questionnaire Administration)
Withdrawn
- Infiltrating Bladder Urothelial Carcinoma
- Quality-of-Life Assessment
- Questionnaire Administration
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020
Prostate Adenocarcinoma, Incontinence Stress, Erectile Dysfunction Following Radical Prostatectomy Trial in Miami (Maximal
Completed
- Prostate Adenocarcinoma
- +2 more
- Maximal urethral length preservation technique of robot assisted radical prostatectomy (RALP).
-
Miami, FloridaLarkin Health System
Feb 17, 2023
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Aug 3, 2023
Prostate Cancer Trial in Indianapolis (68Ga-PSMA-11 PET Scan)
Active, not recruiting
- Prostate Cancer
- 68Ga-PSMA-11 PET Scan
-
Indianapolis, IndianaIndiana University Health University Hospital
May 10, 2022
Upper Urinary Tract Urothelial Carcinoma, Kidney Preservation, HER-2 ADC Trial in Shanghai (RC48 Combined With Tislelizumab)
Recruiting
- Upper Urinary Tract Urothelial Carcinoma
- +3 more
- RC48 Combined With Tislelizumab
-
Shanghai, Shanghai, ChinaEthics Committee of Shanghai Renji Hospital
Jun 20, 2023
Bladder Cancer Trial in Spain (Atezolizumab Injection [Tecentriq], External Beam Radiation Therapy (EBRT))
Active, not recruiting
- Bladder Cancer
- Atezolizumab Injection [Tecentriq]
- External Beam Radiation Therapy (EBRT)
-
Manresa, Barcelona, Spain
- +9 more
Oct 25, 2022
Urinary Bladder Wall Post Transurethral Tumor Resection
Not yet recruiting
- Urinary Bladder Cancer
- MRI
- (no location specified)
Mar 15, 2023
Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)
Not yet recruiting
- Non-Muscle Invasive Bladder Cancer
- HER2
- (no location specified)
Jul 16, 2023
Organ Preservation, Rectal Cancer, Quality of Life Trial in Netherlands (Contact x-ray brachytherapy, Local excision)
Recruiting
- Organ Preservation
- +3 more
- Contact x-ray brachytherapy
- Local excision
-
Leeuwarden, Friesland, Netherlands
- +6 more
Mar 14, 2023
Placenta Accreta Trial in Jakarta Pusat (Jakarta Surgical Uterine Conservation (JSICA) Technique, Standard Hysterectomy)
Completed
- Placenta Accreta
- Jakarta Surgical Uterine Conservation (JSICA) Technique
- Standard Hysterectomy
-
Jakarta Pusat, DKI Jakarta, IndonesiaMaternal Fetal Medicine Division, Obstetric Gynecology Departmen
May 20, 2023
Fluorescence, Indocyanine Green, Rectal Cancer Surgery Trial in Beijing (Fluorescence laparoscopic system)
Recruiting
- Fluorescence
- +2 more
- Fluorescence laparoscopic system
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Sep 10, 2023
Infiltrating Bladder Urothelial Carcinoma Trial in Montpellier (Radiation + cisplatin, Radiation + cisplatin + gemcitabine)
Active, not recruiting
- Infiltrating Bladder Urothelial Carcinoma
- Radiation + cisplatin
- Radiation + cisplatin + gemcitabine
-
Montpellier, FranceCRLC Val d'Aurelle-Paul Lamarque
Dec 20, 2021
Hypofractionated Radiotherapy With Concurrent Gemcitabine in
Not yet recruiting
- Urinary Bladder Cancer
- Chemoradiation
- (no location specified)
Mar 22, 2021
Bladder Cancer Trial in Erlangen (other, radiation, drug)
Recruiting
- Bladder Cancer
- Hyperthermia
- +3 more
-
Erlangen, GermanyDept. of Radiation Therapy, University Hospital Erlangen
May 25, 2022
Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)
Recruiting
- Urinary Bladder Cancer
- Carboplatin-Gemcitabine Cisplatin-Gemcitabine
-
Assiut, EgyptAssiutU
Apr 22, 2023